201 related articles for article (PubMed ID: 28254589)
1. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.
Cho H; Choi JY; Lee SH; Lee JH; Choi YC; Ryu YH; Lee MS; Lyoo CH
Neurobiol Aging; 2017 May; 53():103-111. PubMed ID: 28254589
[TBL] [Abstract][Full Text] [Related]
2. Tau PET in Alzheimer disease and mild cognitive impairment.
Cho H; Choi JY; Hwang MS; Lee JH; Kim YJ; Lee HM; Lyoo CH; Ryu YH; Lee MS
Neurology; 2016 Jul; 87(4):375-83. PubMed ID: 27358341
[TBL] [Abstract][Full Text] [Related]
3. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
4. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.
Visser D; Verfaillie SCJ; Wolters EE; Coomans EM; Timmers T; Tuncel H; Boellaard R; Golla SSV; Windhorst AD; Scheltens P; van der Flier WM; van Berckel BNM; Ossenkoppele R
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1951-1963. PubMed ID: 34997294
[TBL] [Abstract][Full Text] [Related]
5. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Cho H; Mundada NS; Apostolova LG; Carrillo MC; Shankar R; Amuiri AN; Zeltzer E; Windon CC; Soleimani-Meigooni DN; Tanner JA; Heath CL; Lesman-Segev OH; Aisen P; Eloyan A; Lee HS; Hammers DB; Kirby K; Dage JL; Fagan A; Foroud T; Grinberg LT; Jack CR; Kramer J; Kukull WA; Murray ME; Nudelman K; Toga A; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez M; Musiek E; Onyike CU; Riddle M; Rogalski EJ; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Koeppe R; Iaccarino L; Dickerson BC; La Joie R; Rabinovici GD;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S98-S114. PubMed ID: 37690109
[TBL] [Abstract][Full Text] [Related]
6. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
7. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological performance and conversion to Alzheimer's disease in early- compared to late-onset amnestic mild cognitive impairment: CREDOS study.
Ye BS; Seo SW; Lee Y; Kim SY; Choi SH; Lee YM; Kim DH; Han HJ; Na DL; Kim EJ
Dement Geriatr Cogn Disord; 2012; 34(3-4):156-66. PubMed ID: 23037957
[TBL] [Abstract][Full Text] [Related]
10. Widespread distribution of tauopathy in preclinical Alzheimer's disease.
Schultz SA; Gordon BA; Mishra S; Su Y; Perrin RJ; Cairns NJ; Morris JC; Ances BM; Benzinger TLS
Neurobiol Aging; 2018 Dec; 72():177-185. PubMed ID: 30292840
[TBL] [Abstract][Full Text] [Related]
11. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
Joubert S; Gour N; Guedj E; Didic M; Guériot C; Koric L; Ranjeva JP; Felician O; Guye M; Ceccaldi M
Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580
[TBL] [Abstract][Full Text] [Related]
12. Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease.
Aziz AL; Giusiano B; Joubert S; Duprat L; Didic M; Gueriot C; Koric L; Boucraut J; Felician O; Ranjeva JP; Guedj E; Ceccaldi M
Neurobiol Aging; 2017 Jun; 54():22-30. PubMed ID: 28314160
[TBL] [Abstract][Full Text] [Related]
13. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
[TBL] [Abstract][Full Text] [Related]
14. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
[TBL] [Abstract][Full Text] [Related]
15. Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study.
Parbo P; Ismail R; Sommerauer M; Stokholm MG; Hansen AK; Hansen KV; Amidi A; Schaldemose JL; Gottrup H; Brændgaard H; Eskildsen SF; Borghammer P; Hinz R; Aanerud J; Brooks DJ
Neurobiol Dis; 2018 Sep; 117():211-216. PubMed ID: 29902557
[TBL] [Abstract][Full Text] [Related]
16. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.
Cho H; Choi JY; Hwang MS; Kim YJ; Lee HM; Lee HS; Lee JH; Ryu YH; Lee MS; Lyoo CH
Ann Neurol; 2016 Aug; 80(2):247-58. PubMed ID: 27323247
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.
Kim SH; Seo SW; Yoon DS; Chin J; Lee BH; Cheong HK; Han SH; Na DL
Dement Geriatr Cogn Disord; 2010; 29(3):213-23. PubMed ID: 20332639
[TBL] [Abstract][Full Text] [Related]
18. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
[TBL] [Abstract][Full Text] [Related]
19. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
20. Amyloid deposition in early onset versus late onset Alzheimer's disease.
Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
